Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.0K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.0K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current perspectives on β<sub>2</sub>-adrenergic receptor agonists in asthma: navigating from track to track within GINA recommendations.

Expert opinion on pharmacotherapy·2026
Same author

Portopulmonary hypertension and serum endothelin-1 levels in patients with liver cirrhosis.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2026
Same author

Comparative Clinical Presentation of Bronchial Asthma in Adults and Children in North India.

Cureus·2026
Same author

Oxidative stress, antioxidant depletion, and DNA damage in post-COVID-19 patients: evidence of a disrupted redox network and loss of age-dependent antioxidant compensation.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Mucus plugs in COPD and cardiovascular mortality: An emerging risk pathway and the therapeutic potential of mucolytic strategies.

Respiratory medicine·2026
Same author

Respiratory health in a changing environment: environment-adaptive therapies and revised dosing strategies.

Expert review of respiratory medicine·2026

Related Experiment Video

Updated: Mar 12, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

GOLD 2026: Transforming COPD Management with Early Intervention, Multi-dimensional Assessment, and Personalized Care.

Mario Cazzola1, Jyoti Bajpai2, Luigino Calzetta3

  • 1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Via Montpellier, 1, 00133, Rome, Italy. mario.cazzola@uniroma2.it.

Drugs
|March 10, 2026
PubMed
Summary

The 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report updates chronic obstructive pulmonary disease management. It emphasizes personalized, multi-dimensional care beyond spirometry, integrating biomarkers and new therapies for better patient outcomes.

More Related Videos

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K

Related Experiment Videos

Last Updated: Mar 12, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K

Area of Science:

  • Pulmonary Medicine
  • Respiratory Disease Research
  • Clinical Practice Guidelines

Background:

  • Chronic obstructive pulmonary disease (COPD) management traditionally relies on spirometry.
  • Previous guidelines lacked emphasis on multi-dimensional assessment and personalized treatment.
  • The need for updated strategies addressing disease activity and exacerbation prevention is critical.

Purpose of the Study:

  • To outline the key updates and innovations in the 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report.
  • To highlight the shift towards personalized, multi-dimensional COPD management.
  • To introduce new therapeutic targets and strategies for COPD.

Main Methods:

  • Review and synthesis of the latest evidence and expert consensus for COPD management.
  • Integration of spirometric data with multi-dimensional assessments, including disease activity and biomarkers like blood eosinophil counts.
  • Structured approach to pharmacological and non-pharmacological interventions, including new biologic therapies.

Main Results:

  • The 2026 GOLD report emphasizes early diagnosis, multi-dimensional assessment, and personalized treatment for COPD.
  • Key updates include recognizing disease activity as a target, refining the ABE classification, and using blood eosinophil counts for inhaled corticosteroid guidance.
  • Non-pharmacologic interventions are core strategies, dual bronchodilation is the preferred initial pharmacologic step, and biologics are introduced for specific patient groups.

Conclusions:

  • The 2026 GOLD report advances precision medicine in COPD through individualized assessments and early interventions.
  • Significant uncertainties remain regarding biomarker variability, emerging therapies' efficacy, and equitable access.
  • Context-sensitive application and continued validation of new strategies are essential for effective COPD management.